Propecia clinical studies

Start

In the first year of the study, 86% (584 of 679) of the men on PROPECIA maintained hair or increased the number of visible hairs vs 42% (282 of 672) of the men on placebo.

PROPECIA is the first and only FDA-approved pill used for the treatment of male pattern hair loss on the vertex (top of head) and anterior mid-scalp area (middle front of head). There is not sufficient evidence that PROPECIA works for receding hairlines at the temples. PROPECIA is for use by MEN ONLY and should NOT be used by women or children.

In clinical studies for PROPECIA, a small number of men experienced certain sexual side effects, such as less desire for sex, difficulty in achieving an erection, or a decrease in the amount of semen. Each of these side effects occurred in less than 2% of men and went away in men who stopped taking PROPECIA because of them.

End

Leave a Reply

You must be logged in to post a comment.